MENU
Axsome Therapeutics (AXSM) Ownership - Who owns Axsome Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
One World Trade Center
Phone
+1 212 332-3241
Employees
545
Web
https://www.axsome.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.47B
P/E Ratio
N/A
Total Cash
315.66M
Projected Growth
N/A
Total Debt
191.8M
Revenue
291.49M
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
6.58
Total Debt/Equity
N/A
Revenue/Share
6.15 USD as % of share price
Fundamentals
AXSM
Capitalization
4.47B
P/E Ratio
N/A
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
316M
Total Cash/Share
6.58
Total Debt
192M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.15%
Revenue
291M
ROE
N/A
Book Value
103M
P/B Ratio
43.48
Cash Flow
N/A
Earnings
-6.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
2.48
Current Revenue Per Employee
147989.81
Dividends Per Share - Security
N/A
EBITDA
-298.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.76
Revenue To Assets
-53.20
Shares Held By Institutions
4.56B
Shares Outstanding - Current
48M
Total Liabilities
445M
Total Volume MTD
N/A
Value
-1
Gain YTD
17.716
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a provider of biopharmaceutical services for pain and other nervous system
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
One World Trade Center
Phone
+1 212 332-3241
Employees
545
Web
https://www.axsome.com